LeukoSTAT™ Supplement Focuses on the Critical Care Environment

Posted By: Anonymous | Posted On: Mar 31,2010 18:30 pm | View: 31
IMULAN is now focusing on critical care applications for leukoSTAT™, an environment which often has limited options to support patients. The ImSAIDs® have been previously evaluated in a variety of in vivo critical care models, including sepsis (e.g. SIRS) and inflammation of the pancreas, lungs, intestines, nervous system, and joints. Read More: http://www.prweb.com/releases/2010/04/prweb3812284.htm